Workflow
Carisma Therapeutics Inc.
icon
Search documents
Carrefour, Carmila, Unlimitail and JCDecaux join forces to accelerate the development of retail media across Carrefour and Carmila sites in France and Spain
Globenewswire· 2025-12-09 16:40
Core Insights - Carrefour, Carmila, Unlimitail, and JCDecaux have formed a strategic partnership to enhance retail media through indoor Digital Out-of-Home (DOOH) and outdoor advertising at shopping centers in France and Spain [1][2][10] Partnership Details - The partnership aims to create a new media ecosystem at Carrefour and Carmila sites, with JCDecaux managing and upgrading advertising assets [2] - This collaboration aligns with Carrefour's transformation strategy, focusing on innovation and long-term value creation for real estate assets [2][9] Implementation Strategy - In France, the project will introduce 75-inch LCD digital screens and 81-inch LED screens in access areas, enhancing the advertising format [3][4] - The deployment will cover 161 shopping center malls and 297 access areas, marking JCDecaux's largest multi-site project in France [4] Expansion Plans - In Spain, JCDecaux will develop an indoor DOOH offer across 91 shopping centers and an outdoor offer across 88 access areas starting in 2027 [5] Technological Advancements - The digital assets will utilize low-energy technologies, and analogue street furniture will be upgraded with energy-efficient LED lighting [6] Retail Media Integration - The new OOH/DOOH network will integrate with Unlimitail's retail media offering, allowing for omnichannel strategies and programmatic DOOH campaigns [7][8] - Advertisers will have access to performance measurement tools based on aggregated data from Carrefour and Unlimitail [8] Strategic Goals - The project aims to modernize shopping centers, enhance visitor experience, and create new revenue streams through retail media [9][10] - The partnership is expected to leverage the strengths of Carrefour's audience, Carmila's real estate expertise, Unlimitail's retail media capabilities, and JCDecaux's outdoor advertising leadership [10]
Stock Market Declines: A Snapshot of Recent Movements
Financial Modeling Prep· 2025-10-10 22:00
Company Performance - Dreamland Limited Class A Ordinary Shares (NASDAQ:TDIC) experienced a significant drop of 80.33% to $1.2, with a trading volume surge to over 8.3 million shares, indicating a strong market reaction to recent developments [1] - Bollinger Innovations, Inc. (BINI) saw its price decrease by 49.14% to $0.71 amidst a substantial sell-off, with volume exceeding 23 million shares, reflecting a critical reassessment by investors [2] - A SPAC III Acquisition Corp. (ASPCR) faced a 46.29% decline in its price to $0.11, with low trading volume at 112, highlighting niche interest in SPAC investments [3] - Carisma Therapeutics, Inc. (CARM) experienced a 43.92% decrease in its price to $0.15, with volume reaching over 12.6 million, reflecting market concerns regarding its pipeline's progress despite a collaboration with Moderna Inc. [4] - Tian Ruixiang Holdings Ltd (TIRX) saw its price fall by 42.75% to $1.34, with a decrease from a year high of $13.25, indicating challenges within the insurance brokerage sector [5] Market Dynamics - The stock market has shown notable declines across various companies, emphasizing the dynamic nature of valuations and the rapid changes faced by firms in different industries [6]
Dow Surges 150 Points; US Consumer Sentiment Edges Lower - CARISMA Therapeutics (NASDAQ:CARM), Bollinger Innovations (NASDAQ:BINI)
Benzinga· 2025-10-10 14:23
Market Overview - U.S. stocks traded higher, with the Dow Jones index gaining over 150 points, up 0.39% to 46,542.50, NASDAQ rose 0.29% to 23,090.45, and S&P 500 increased 0.26% to 6,752.41 [1] - Consumer staples shares increased by 0.7%, while energy stocks fell by 1% [1] Consumer Sentiment - The University of Michigan consumer sentiment index decreased to 55 in October from 55.1 in September, slightly above market estimates of 54.2 [2][10] Commodity Prices - Oil prices fell by 2.4% to $60.05, while gold rose by 0.6% to $3,995.60. Silver increased by 2.3% to $48.250, and copper rose by 0.7% to $5.1575 [5] European Markets - European shares were mostly lower, with the eurozone's STOXX 600 down 0.2%. Spain's IBEX 35 Index rose 0.5%, while London's FTSE 100, Germany's DAX 40, and France's CAC 40 all fell by 0.1% to 0.2% [6] Asian Markets - Asian markets closed mostly lower, with Japan's Nikkei 225 down 1.01%, Hong Kong's Hang Seng index down 1.73%, and China's Shanghai Composite down 0.94%. India's BSE Sensex rose by 0.40% [7] Company Stock Movements - Quoin Pharmaceuticals, Ltd. shares surged 170% to $22.00 following a $104.5 million private placement [9] - ESS Tech, Inc. shares increased 102% to $3.4750 after announcing an agreement for a battery system addition [9] - Safe & Green Holdings Corp. shares rose 90% to $6.16 after regaining Nasdaq compliance [9] - Bollinger Innovations, Inc. shares dropped 58% to $0.5820 due to a move to OTC markets [9] - Carisma Therapeutics, Inc. shares fell 44% to $0.1538 after announcing a $5 million investment [9] - Tian Ruixiang Holdings Ltd. shares decreased 39% to $1.4310 following a $3 million registered direct offering [9]
Dow Surges 150 Points; US Consumer Sentiment Edges Lower
Benzinga· 2025-10-10 14:23
Market Overview - U.S. stocks traded higher, with the Dow Jones index gaining over 150 points, up 0.39% to 46,542.50, NASDAQ rose 0.29% to 23,090.45, and S&P 500 increased 0.26% to 6,752.41 [1] - Consumer staples shares increased by 0.7%, while energy stocks fell by 1% [1] Consumer Sentiment - The University of Michigan consumer sentiment index decreased to 55 in October from 55.1 in September, slightly above market estimates of 54.2 [2][10] Commodity Prices - Oil prices fell by 2.4% to $60.05, while gold rose by 0.6% to $3,995.60. Silver increased by 2.3% to $48.250, and copper rose by 0.7% to $5.1575 [5] European Markets - European shares were mostly lower, with the eurozone's STOXX 600 down 0.2%. Spain's IBEX 35 Index rose by 0.5%, while London's FTSE 100, Germany's DAX 40, and France's CAC 40 all experienced slight declines [6] Asian Markets - Asian markets closed mostly lower, with Japan's Nikkei 225 down 1.01%, Hong Kong's Hang Seng index down 1.73%, and China's Shanghai Composite down 0.94%. India's BSE Sensex was the exception, rising by 0.40% [7] Company Stock Movements - Quoin Pharmaceuticals, Ltd. shares surged 170% to $22.00 following a $104.5 million private placement [9] - ESS Tech, Inc. shares increased 102% to $3.4750 after announcing an agreement for a battery system addition [9] - Safe & Green Holdings Corp. shares rose 90% to $6.16 after regaining Nasdaq compliance [9] - Bollinger Innovations, Inc. shares dropped 58% to $0.5820 due to a move to OTC markets [9] - Carisma Therapeutics, Inc. shares fell 44% to $0.1538 after announcing a $5 million investment as part of a merger [9] - Tian Ruixiang Holdings Ltd. shares decreased 39% to $1.4310 following a $3 million registered direct offering [9]
Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Applied Digital (NASDAQ:APLD), Baosheng Media Gr (NASDAQ:BAOS)
Benzinga· 2025-10-10 09:06
Group 1 - Applied Digital Corp (NASDAQ:APLD) shares increased by 24.6% to $36.50 in pre-market trading following the release of its fiscal first-quarter 2026 earnings report [1][2] - The company reported first-quarter revenue of $64.22 million, surpassing analyst estimates of $49.99 million [1] - Applied Digital's first-quarter adjusted loss was three cents per share, better than the analyst expectations of a loss of 13 cents per share [1] Group 2 - Safe & Green Holdings Corp (NASDAQ:SGBX) saw a significant gain of 85.5% to $6.01 in pre-market trading after regaining Nasdaq compliance [5] - Brookfield Corp (NYSE:BN) surged 51.1% to $68.00 following the completion of a three-for-two stock split [5] - SWK Holdings Corp (NASDAQ:SWKH) rose 45.5% to $21.00 after Runway Growth Finance Corp agreed to acquire the company [5]
Dow Tumbles Over 1%; Nio Shares Edge Lower After Q2 Results
Benzinga· 2025-09-02 16:55
Company Performance - Nio reported fiscal second-quarter revenue of 19.01 billion Chinese yuan ($2.65 billion), representing a year-over-year increase of 9.0% and a sequential growth of 57.9% [2] - The company reported an adjusted loss per share of 1.85 yuan (25 cents), an improvement from a loss of 2.21 yuan in the same quarter last year, and better than analysts' expectations of a 30 cents loss [3] - For Q3 2025, Nio expects vehicle deliveries to be between 87,000 and 91,000 units, indicating a growth of approximately 40.7% to 47.1% compared to the same period in 2024 [3] Stock Movements - Cytokinetics, Incorporated shares surged 38% to $48.74 following positive clinical trial results for Aficamten [8] - Carisma Therapeutics, Inc. saw a 90% increase in shares to $0.4088 after announcing a $5 million investment from Ocugen [8] - United Therapeutics Corporation shares rose 39% to $422.36 after its TETON-2 study met primary efficacy endpoints [8] - CleanCore Solutions, Inc. shares dropped 58% to $2.8800 due to a PIPE agreement announcement [8] - Canopy Growth Corporation shares fell 16% to $1.5095 following a $200 million offering disclosure [8] - Celularity Inc. shares decreased by 37% to $2.4500 after receiving a Nasdaq notification regarding Form 10-Q [8] Market Overview - U.S. stocks traded lower, with the Dow Jones index down 1.08% to 45,052.65, NASDAQ down 1.60% to 21,111.52, and S&P 500 down 1.32% to 6,374.93 [1] - European shares also declined, with the eurozone's STOXX 600 falling 1.17% and major indices in Spain, London, Germany, and France also experiencing losses [7] - Asian markets closed mostly lower, with Japan's Nikkei 225 gaining slightly while other major indices in Hong Kong, China, and India fell [9]
Carisma Therapeutics Provides Corporate Updates
Prnewswire· 2025-03-31 20:30
Company to explore strategic alternatives to advance liver fibrosis and oncology assets and reduce operational cash burn Pipeline Updates Fibrosis Ex Vivo Oncology In Vivo Program (Moderna Collaboration) Our liver fibrosis program is based upon the discovery of a key efferocytosis defect in the macrophages that reside within the livers of patients with fibrosis. Using a novel mRNA/LNP approach, our product candidate, CT-2401, aims to reverse fibrotic disease and improve the outcomes of patients with advance ...